These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 23823089)

  • 41. [Hotspot report of the 54th American Society of Hematology Annual Meeting Drug resistance of multiple myeloma].
    Hao M; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2013 Apr; 34(4):374-6. PubMed ID: 23668218
    [No Abstract]   [Full Text] [Related]  

  • 42. Overview of the International Myeloma Workshop 2013 Kyoto.
    Shimizu K
    Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):2-4. PubMed ID: 24461800
    [No Abstract]   [Full Text] [Related]  

  • 43. Inflammatory aggregates.
    Visan I
    Nat Immunol; 2021 Sep; 22(9):1071. PubMed ID: 34429545
    [No Abstract]   [Full Text] [Related]  

  • 44. [Mechanisms of drug resistance and sensitivity concerning novel agents for multiple myeloma].
    Tokuhira M
    Rinsho Ketsueki; 2016 May; 57(5):563-74. PubMed ID: 27263780
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [How to overcome the cell adhesion-mediated drug resistance in multiple myeloma].
    Furukawa Y; Kikuchi J
    Rinsho Ketsueki; 2013 Jun; 54(6):513-21. PubMed ID: 23823089
    [No Abstract]   [Full Text] [Related]  

  • 46. Epigenetic mechanisms of cell adhesion-mediated drug resistance in multiple myeloma.
    Furukawa Y; Kikuchi J
    Int J Hematol; 2016 Sep; 104(3):281-92. PubMed ID: 27411688
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drug resistance and drug development in multiple myeloma.
    Dalton WS
    Semin Oncol; 2002 Dec; 29(6 Suppl 17):21-5. PubMed ID: 12520481
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeted therapy of multiple myeloma based upon tumor-microenvironmental interactions.
    Anderson KC
    Exp Hematol; 2007 Apr; 35(4 Suppl 1):155-62. PubMed ID: 17379101
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug resistance in multiple myeloma: approaches to circumvention.
    Dalton WS; Jove R
    Semin Oncol; 1999 Oct; 26(5 Suppl 13):23-7. PubMed ID: 10528891
    [TBL] [Abstract][Full Text] [Related]  

  • 50.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.